Exercise training in intermittent claudication: Effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells

Thrombosis and Haemostasis

Volumn 108, Issue 5, 2012, Pages 824-831

  Nowak, Witold N ^a   Mika, Piotr ^b   Nowobilski, Roman ^c   Kusinska, Katarzyna ^a   Bukowska Strakova, Karolina ^a   Nizankowski, Rafal ^c   Jozkowicz, Alicja ^a   Szczeklik, Andrzej ^c   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF PHYSICAL EDUCATION   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Heme oxy genase 1; Inflammation; Ischaemia; MicroRNA; Oxidative stress

Indexed keywords

ANTIOXIDANT; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HEME OXYGENASE 2; INTERLEUKIN 6; MICRORNA 146A; MICRORNA 155; MICRORNA 200C; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANGIOGENESIS; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CLINICAL ARTICLE; ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; INFLAMMATION; INTERMITTENT CLAUDICATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; TRAINING; TREADMILL EXERCISE;

ADULT STEM CELLS; AGED; ANTIOXIDANTS; ARTERIAL OCCLUSIVE DISEASES; CHEMOKINE CCL2; CYTOKINES; EXERCISE THERAPY; FEMALE; GENE EXPRESSION; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; RNA, MESSENGER; SUPEROXIDE DISMUTASE; WALKING;

EID: 84870001763     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-04-0278     Document Type: Article

References (39)

1. Meru AV, Mittra S, Thyagarajan B, et al. Intermittent claudication: an overview. Atherosclerosis 2006; 187: 221-237.
2. Murabito JM, D'Agostino RB, Silbershatz H, et al. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 1997; 96: 44-49.
3. Nawaz S, Walker RD, Wilkinson CH, et al. The inflammatory response to upper and lower limb exercise and the effects of exercise tr aining in patients with claudi-cation. J Vasc Surg 2001; 33: 392-399.
4. Turton E P, Spark JI, Mercer KG, et al. Exercise-induced neutrophil activation in claudicants: a physiological or pathological response to exhaustive exercise? Eur J Vasc Endovasc Surg 1998; 16: 192-196.
5. Hickey NC, Shearman C P, Gosling P, et al. Assessment of intermittent claudi-cation by quantitation of exercise-induced microalbuminuria. Eur J Vasc Surg 1990; 4: 603-606.
6. Diamantopoulos EJ, Charitos D, Georgopoulos V, et al. Oxygen Free Radicals and the Effect of a Free Radical Scavenger in Patients with Intermittent Claudication. Vasc Endovasc Surg 2000; 34: 167-174.
7. Edwards AT, Blann AD, Suarez-Mendez VJ, et al. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 1994; 81: 1738-1741.
8. Finaud J, Lac G, Filaire E. Oxidative stress: relationship with exercise and training. Sports Med 2006; 36: 327-358.
9. Hulsmans M, De Keyzer D, Holvoet P. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 2011; 25: 2515-2527.
10. Zernecke A. MicroRNAs in the regulation of immune cell functions - implications for atherosclerotic vascular disease. Thromb Haemost 2012; 107: 626-633.
11. Stewart AHR, Lamont PM. Exercise training for claudication. Surgeon 2007; 5: 291-299.
12. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease12. J Vasc Surg 1996; 23: 104-115.
13. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 45 Suppl: S5-6.
14. Hiatt WR, Hirsch AT, Regensteiner JG, et al. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation 1995; 92: 614-621.
15. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
16. McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. J Am Med Assoc 2009; 301: 165-174.
17. Fleming I. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 2005; 118: 4103-4111.
18. Obi S, Masuda H, Shizuno T, Sato A, Yamamoto K, Ando J, et al. Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells. AJP: Cell Physiology 2012; epub ahead of print.
19. Shaffer RG, Greene S, Arshi A, et al. Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease. Vasc Med 2006; 11: 219-226.
20. Schlager O, Giurgea A, Schuhfried O, et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial. Atherosclerosis 2011; 217:240-248
21. Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human en-dothelial cells: lesson from the promoter allelic variants. Arterioscl Thromb Vasc Biol 2010; 30: 1634-1641.
22. Thompson D, Basu-Modak S, Gordon M, et al. Exercise-induced expression of heme oxygenase-1 in human lymphocytes. Free Radic Res 2005; 39: 63-69.
23. Niess A, Sommer M, Schneider M, et al. Physical exercise-induced expression of inducible nitric oxide synthase and heme oxygenase-1 in human leukocytes: effects of RRR-a-tocopherol supplementation. Antioxid Redox Signal 2000; 2: 113-126.
24. Tauler P, Sureda A, Cases N, et al. Increased lymphocyte antioxidant defences in response to exhaustive exercise do not prevent oxidative damage. J Nutr Biochem 2006; 17: 665-671.
25. Murabito JM, Keyes MJ, Guo C-Y, et al. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis 2009; 203: 509-514.
26. Chaparala RPC, Orsi NM, Lindsey NJ, et al. Inflammatory profiling of peripheral arterial disease. Ann Vasc Surg 2009; 23: 172-178.
27. McDermott MM, Liu K, Ferrucci L, et al. Circulating Blood Markers and Functional Impairment in Peripheral Arterial Disease. J Am Geriatr Soc 2008; 56: 1504-1510.
28. Hoogeveen RC, Morrison A, Boerwinkle E, et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005; 183: 301-307.
29. Heil M, Ziegelhoeffer T, Pipp F, et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002; 283: H2411-2419.
30. Park H-J, Chang K, Park CS, et al. Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction. Intern J Cardiol 2008; 130: 409-413.
31. Melanson SEF, Green SM, Wood MJ, et al. Elevation of Myeloperoxidase in Conjunction With Cardiac-Specific Markers After Marathon Running. Am J Clin Pathol 2006; 126: 888-893.
32. Niess AM, Passek F, Lorenz I, et al. Expression of the antioxidant stress protein heme oxygenase-1 (HO-1) in human leukocytes. Free Radic Biol Med 1999; 26: 184-192.
33. Brevetti G, Schiano V, Laurenzano E, et al. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J 2008; 29: 224-230.
34. Turton EPL, Coughlin PA, Kester RC, et al. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg 2002; 23: 309-316.
35. Killewich LA, Macko RF, Montgomery PS, et al. Exercise training enhances endogenous fibrinolysis in peripheral arterial disease. J Vasc Surg 2004; 40: 741-745.
36. Brevetti G, De Caterina M, Martone VD, et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 2001; 24: 193-199.
37. Andreozzi GM, Martini R, Cordova R, et al. Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease? Int Angiol 2007; 26: 245-252.
38. Kirk G, Hickman P, McLaren M, et al. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD). Eur J Vasc Endovasc Surg 1999; 18: 434-438.
39. Palmer-Kazen U, Religa P, Wahlberg E. Exercise in patients with intermittent claudication elicits signs of inflammation and angiogenesis. Eur J Vasc Endovasc Surg 2009; 38: 689-696.